
Gilead Sciences
GILDNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$135.13
Day High
$137.20
Day Low
$133.55
Prev. Close
$136.22
VolumeShares traded today.
11.32M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$166.90B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
18.29
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$157.29
52W LowLowest price over the past 52 weeks.
$104.46
50D MAAverage closing price over the last 50 trading days.
$135.10
200D MAAverage closing price over the last 200 trading days.
$128.66
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+3.0%1M
+4.3%6M
+5.8%YTD
+10.6%1Y
+22.1%About
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
www.gilead.comCompany Facts
Similar stocks
HealthcareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade GILD
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.